Key result
FOXC1 drives VSMC foam cell formation and plaque instability via CD68 and CYBA activation.
Why the study?
Does the transcription factor FOXC1 promote vascular smooth muscle cell-derived foam cell formation and atherosclerotic plaque instability by regulating CD68 and CYBA?
Does the transcription factor FOXC1 promote vascular smooth muscle cell-derived foam cell formation and atherosclerotic plaque instability by regulating CD68 and CYBA?
Answers are grounded in this paper and cite their sources.
This study identifies FOXC1 as a novel upstream transcriptional regulator of CD68 and CYBA that drives VSMC-derived foam cell formation and atherosclerotic plaque instability, offering potential diagnostic biomarkers and therapeutic targets.
The instability of atherosclerotic plaques, particularly intraplaque hemorrhage (IPH), drives life‐threatening cardiovascular events, a process in which vascular smooth muscle cell (VSMC)‐derived foam cells play a significant role. We aim to identify key biomarkers associated with VSMC‐derived foam cells and IPH by analyzing data from human IPH datasets and VSMC‐derived foam cell datasets (GSE163154, GSE68021, GSE28829, and GSE43292). Weighted gene co‐expression network analysis (WGCNA), differential expression analysis, and machine learning algorithms (LASSO and SVM‐RFE) were employed to identify hub genes. The identified genes were validated in independent datasets and in experimental models, including oxidized low‐density lipoprotein‐stimulated VSMCs and atherosclerotic aortic tissues of high‐fat diet‐fed ApoE − / − mice. Transcription factor (TF) prediction and dual‐luciferase reporter assays were performed to explore upstream regulatory mechanisms. We identified CD68 and CYBA as key hub genes significantly upregulated in both VSMC‐derived foam cells and unstable atherosclerotic plaques, with high diagnostic accuracy (AUC > 0.9) by ROC analysis. Experimental validation confirmed their upregulated expression. FOXC1 was identified as a common upstream transcription factor regulating both CD68 and CYBA. FOXC1 protein levels were elevated in VSMC‐derived foam cells, and dual‐luciferase assays confirmed its direct activation of CD68 and CYBA promoters. FOXC1 overexpression promoted CD68 and CYBA expression and enhanced lipid accumulation in VSMCs, while FOXC1 knockdown exerted opposite effects. Immune infiltration analysis revealed significant correlations between these hub genes and immune cell populations in unstable plaques. This study identifies FOXC1 as a key TF regulating CD68 and CYBA expression, thereby promoting VSMC‐derived foam cell formation and plaque instability.
No takes yet. Share an insight, caveat, or question.
Qian et al. (2026) studied Atherosclerosis and plaque instability (n=10). FOXC1 overexpression or knockdown and ox-LDL stimulation / High-fat diet vs. Untreated control VSMCs / C57BL/6 control mice was evaluated on Diagnostic accuracy (AUC) and expression of hub genes (CD68 and CYBA) and upstream transcription factor FOXC1 in VSMC-derived foam cells and unstable atherosclerotic plaques (p=<0.05). FOXC1 directly activates CD68 and CYBA promoters, which serve as hub genes for VSMC-derived foam cell formation and plaque instability with high diagnostic accuracy.
Synapse has enriched 10 related papers. Consider them for comparative context: